Lambert-Eaton myasthenic syndrome.
Newsom-Davis, J
Lambert-Eaton myasthenic syndrome. [electronic resource] - Revue neurologique Feb 2004 - 177-80 p. digital
Publication Type: Journal Article; Review
0035-3787
10.1016/s0035-3787(04)70888-7 doi
4-Aminopyridine--analogs & derivatives
Amifampridine
Autoantibodies--immunology
Autoantigens--immunology
Autoimmune Diseases of the Nervous System--diagnosis
Calcium Channels, P-Type--immunology
Calcium Channels, Q-Type--immunology
Carcinoma, Small Cell--complications
Cholinesterase Inhibitors--therapeutic use
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Lambert-Eaton Myasthenic Syndrome--diagnosis
Lung Neoplasms--complications
Neoplasm Proteins--immunology
Plasmapheresis
Potassium Channel Blockers--therapeutic use
Pyridostigmine Bromide--therapeutic use
Lambert-Eaton myasthenic syndrome. [electronic resource] - Revue neurologique Feb 2004 - 177-80 p. digital
Publication Type: Journal Article; Review
0035-3787
10.1016/s0035-3787(04)70888-7 doi
4-Aminopyridine--analogs & derivatives
Amifampridine
Autoantibodies--immunology
Autoantigens--immunology
Autoimmune Diseases of the Nervous System--diagnosis
Calcium Channels, P-Type--immunology
Calcium Channels, Q-Type--immunology
Carcinoma, Small Cell--complications
Cholinesterase Inhibitors--therapeutic use
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Lambert-Eaton Myasthenic Syndrome--diagnosis
Lung Neoplasms--complications
Neoplasm Proteins--immunology
Plasmapheresis
Potassium Channel Blockers--therapeutic use
Pyridostigmine Bromide--therapeutic use